Home Clinical Trials Browse by State Browse by City Multiple Sclerosis Guides About Contact

🧬 Paid Multiple Sclerosis Clinical Trials

Browse recruiting multiple sclerosis clinical trials across the United States. Find eligibility information, locations and research opportunities near you.

Loading...
Active Studies
Multiple Sclerosis
Condition

Active Clinical Trials for Multiple Sclerosis

Showing live studies from ClinicalTrials.gov. Data refreshes daily.

Loading studies...

Disclaimer: This content is for educational purposes and is not medical advice. Always consult a qualified healthcare provider for medical guidance.

About Multiple Sclerosis

Multiple Sclerosis (MS) is an autoimmune disease where the immune system attacks the protective myelin sheath covering nerve fibers. Clinical trials investigate disease-modifying therapies, remyelination strategies, and symptomatic treatments.

Common Symptoms

Fatigue, numbness or tingling, weakness, vision problems, balance issues, bladder dysfunction, cognitive changes, spasticity, pain

Risk Factors

Age (20-40), female gender, family history, certain infections (Epstein-Barr), vitamin D deficiency, smoking, obesity, Northern latitude

Treatment Overview

Treatment includes disease-modifying therapies (interferons, glatiramer acetate, S1P receptor modulators, monoclonal antibodies), corticosteroids for relapses, and symptomatic treatments. Clinical trials explore BTK inhibitors, remyelinating agents, and cell-based therapies.

Why Participate?

MS clinical trials are vital for developing treatments that can stop disease progression, repair nerve damage, and improve quality of life for those living with MS.

Related Conditions

States with Multiple Sclerosis Clinical Trials

Cities with Multiple Sclerosis Clinical Trials

Frequently Asked Questions About Multiple Sclerosis Clinical Trials

MS clinical trials test new medications and therapies to reduce relapses, slow disease progression, and manage symptoms of multiple sclerosis.
Eligibility depends on MS type (relapsing-remitting, primary progressive, secondary progressive), disease activity, and prior treatments.
Compensation varies. Participants may receive $50-$200 per visit plus travel reimbursement. Study medications and monitoring are typically provided.
Yes, participants receive regular neurological assessments and monitoring. All trials have independent safety committees and ethical oversight.